Cargando…
Matrix metalloproteinases and their inhibitors in canine mammary tumors
BACKGROUND: Malignant canine mammary tumors represent 50% of all neoplasms in female dogs. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are thought to be involved in tumor progression, and they are also associated with the reactive stroma, which provides struc...
Autores principales: | Aresu, Luca, Giantin, Mery, Morello, Emanuela, Vascellari, Marta, Castagnaro, Massimo, Lopparelli, Rosa, Zancanella, Vanessa, Granato, Anna, Garbisa, Spiridione, Aricò, Arianna, Bradaschia, Alice, Mutinelli, Franco, Dacasto, Mauro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141405/ https://www.ncbi.nlm.nih.gov/pubmed/21726449 http://dx.doi.org/10.1186/1746-6148-7-33 |
Ejemplares similares
-
The role of vascular endothelial growth factor and matrix metalloproteinases in canine lymphoma: in vivo and in vitro study
por: Aricò, Arianna, et al.
Publicado: (2013) -
Global Gene Expression Analysis of Canine Cutaneous Mast Cell Tumor: Could Molecular Profiling Be Useful for Subtype Classification and Prognostication?
por: Giantin, Mery, et al.
Publicado: (2014) -
Validation of epigenetic mechanisms regulating gene expression in canine B-cell lymphoma: An in vitro and in vivo approach
por: Da Ros, Silvia, et al.
Publicado: (2018) -
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule
por: Zorzan, Eleonora, et al.
Publicado: (2018) -
Mutational Hotspot of TET2, IDH1, IDH2, SRSF2, SF3B1, KRAS, and NRAS from Human Systemic Mastocytosis Are Not Conserved in Canine Mast Cell Tumors
por: Zorzan, Eleonora, et al.
Publicado: (2015)